U-shaped-aggressiveness of SARS-CoV-2: Period between onset of nonspecific-specific symptoms for COVID-19. A population-based cohort study
U-shaped-aggressiveness of SARS-CoV-2: Period between onset of nonspecific-specific symptoms for COVID-19. A population-based cohort study
Abstract BackgroundEarly identification of different COVID-19 clinical presentations may depict distinct pathophysiological mechanisms and guide management strategies. ObjectiveTo determine the aggressiveness of SARS-CoV-2 using symptom progression in COVID-19 patients. DesignHistoric cohort study of Mexican patients. Data from January-April 2020 were provided by the Health Ministry. SettingPopulation-based. Patients registered in the Epidemiologic Surveillance System in Mexico. ParticipantsSubjects who sought medical attention for suspicion of COVID-19. All patients were subjected to RT-PCR testing for SARS-CoV-2. MeasurementsWe measured the period between onset of nonspecific to specific symptoms for COVID-19 (PONSS) and compared it to the primary outcomes (mortality and pneumonia). Results65,500 patients were included. Reported fatalities and pneumonia were 2176 (3.32%), and 11568 (17.66%), respectively. According to the PONSS, patients were distributed as follows: 14.89% in <24 hours, 43.25% between 1-3 days, 31.87% between 4-7 days and 9.97% >7 days. The distribution for mortality and pneumonia was 5.2% and 22.5% in <24 hours, 2.5% and 14% between 1-3 days, 3.6% and 19.5% between 4-7 days, 4.1% and 20.6% >7 days, respectively (p<0.001). Adjusted-risk of mortality was (OR [95% CI], p-value): <24 hours= 1.75 [1.55-1.98], p<0.001; 1-3 days= 1 (reference value); 4-7 days= 1.53 [1.37-1.70], p<0.001; >7 days= 1.67 [1.44-1.94], p<0.001. For pneumonia: <24 hours= 1.49 [1.39-1.58], p<0.001; 1-3 days= 1; 4-7 days= 1.48 [1.41-1.56], p<0.001; >7 days= 1.57 [1.46-1.69], p<0.001. LimitationsUsing a database fed by large numbers of people carries the risk of data inaccuracy. However, this imprecision is expected to be random and data are consistent with previous studies. ConclusionThe PONSS shows a U-shaped SARS-CoV-2 aggressiveness pattern. Further studies are needed to corroborate the time-related pathophysiology behind these findings.
Zald¨avar-P¨|rez Pav¨?n Andrea、Mart¨anez-Gil Mercedes、Morgenstern-Kaplan Dan、Talavera Juan O.、Buitano-Tang Bruno
Centro de Investigaci¨?n en Ciencias de la Salud An¨¢huac (CICSA), Universidad An¨¢huac M¨|xicoCentro de Investigaci¨?n en Ciencias de la Salud An¨¢huac (CICSA), Universidad An¨¢huac M¨|xicoCentro de Investigaci¨?n en Ciencias de la Salud An¨¢huac (CICSA), Universidad An¨¢huac M¨|xicoDepartment of Medical Education and Research, ABC Medical CenterCentro de Investigaci¨?n en Ciencias de la Salud An¨¢huac (CICSA), Universidad An¨¢huac M¨|xico
医学研究方法临床医学内科学
COVID-19EpidemiologyPublic HealthPandemicMortality
Zald¨avar-P¨|rez Pav¨?n Andrea,Mart¨anez-Gil Mercedes,Morgenstern-Kaplan Dan,Talavera Juan O.,Buitano-Tang Bruno.U-shaped-aggressiveness of SARS-CoV-2: Period between onset of nonspecific-specific symptoms for COVID-19. A population-based cohort study[EB/OL].(2025-03-28)[2025-05-25].https://www.medrxiv.org/content/10.1101/2020.10.28.20221697.点此复制
评论